Christopher Tovey
Chief Executive Officer at DESTINY PHARMA PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam George | M | 54 |
GW Pharma Ltd.
 GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999.
GW Research Ltd.
 GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | 17 years |
| Leif Gunnar Håkansson | M | 82 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| William Love | M | 62 | 28 years | |
| Debra Stephanie Barker | M | 61 | 4 years | |
| Jan Peter Ernst Christensson | M | - |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Shaun Claydon | M | 56 | 6 years | |
| Tomas D. Bertmark | M | - |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Jerker Olof Ringström | M | 81 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Geoffrey Guy | M | 70 |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995.
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | 26 years |
| Marc Richard Tullgren | M | 59 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| James Ford | M | - | 29 years | |
| Jean-Christophe Tellier | M | 65 | 13 years | |
| Aled Williams | M | - | 2 years | |
| William Rhys-Williams | M | - | 26 years | |
| James Stearns | M | - | 2 years | |
| Jim Lees | M | - | 7 years | |
| Sally Jackson | F | - | 23 years | |
| Timothy Woodthorpe | M | - | 24 years | |
| Anthony Rudd | M | 76 | 1 years | |
| Jan Nilsson | M | 75 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Anders Månsson | M | 57 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | 7 years |
| Stig Thomas Jivung | M | 73 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| David Redfern | M | 57 | 30 years | |
| Nigel Brooksby | M | - | 2 years | |
| Derek Gregory Batcheller | M | 67 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Iris Löw-Friedrich | M | 63 | 18 years | |
| Lars Olof Hedbys | M | 67 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | - |
| Graham Rivers | M | - | 26 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Giacobello | M | 54 | 4 years | |
| Harriet Edelman | F | 68 | 5 years | |
| Fabrice Enderlin | M | - | 9 years | |
| Richard D. Forrest | M | 75 | - | |
| Alex Howarth | M | 55 | 10 years | |
| Julian Heslop | M | 70 | 13 years | |
| Christopher Viehbacher | M | 64 | 20 years | |
| Elmar Schnee | M | 65 | 7 years | |
| Cabot Brown | M | 63 | 8 years | |
| Catherine Mackey | M | 68 | 4 years | |
| Albrecht de Graeve | M | 69 | 14 years | |
| William Louv | M | - | 21 years | |
| Jean-Pierre Kinet | M | 70 | - | |
| Thomas Leysen | M | 63 | 3 years | |
| Nunzio Antonelli | M | - | - | |
| Armand de Decker | M | - | - | |
| Norman J. Ornstein | M | - | - | |
| Stephen Wright | M | 71 | 13 years | |
| Julian Gangolli | M | 66 | 4 years | |
| Mohammed Khoso Baluch | M | 66 | 8 years | |
| Alicia Secor | F | 62 | 4 years | |
| Murray Stewart | M | 63 | 17 years | |
| Bill Silbey | M | 65 | - | |
| William Arthur Waldegrave | M | 78 | 4 years | |
| Douglas B. Snyder | M | 60 | 11 years | |
| Paul Berns | M | 57 | 11 years | |
| Richard Sykes | M | 79 | 7 years | |
| Peter Traber | M | 69 | 3 years | |
| Jean-Pierre Garnier | M | 75 | 8 years | |
| Mark McDade | M | 69 | 8 years | |
| Thomas Gerard Lynch | M | 67 | 10 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| Ian Maurice Gray Prosser | M | 81 | 9 years | |
| Robert Wilson | M | 81 | 11 years | |
| Christopher Gent | M | 75 | 11 years | |
| H. Culp | M | 60 | 9 years | |
| Robert Carr | M | - | 26 years | |
| Michèle Barzach | M | - | 7 years | |
| Crispin Davis | M | 75 | 10 years | |
| Thomas Fulton Wilson McKillop | M | 81 | 7 years | |
| John David Coombe | M | 79 | 5 years | |
| Lisa Trivison Beck | F | 62 | 24 years | |
| Clare Khan | M | 72 | 11 years | |
| Melissa Beelen | F | - | 12 years | |
| Ian Pitfield | M | 58 | 23 years | |
| Elizabeth A. Tarka | M | 57 | 12 years | |
| John Lepore | M | - | 15 years | |
| Randall K. Johnson | M | 77 | 20 years | |
| Hwa Jin Song Montesano | F | 53 | 4 years | |
| Lisa Bright | F | 56 | 17 years | |
| Joseph M. Spagnardi | M | 60 | 11 years | |
| Nicholas Hill | M | - |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | 4 years |
| M. Berrey | M | 57 | 3 years | |
| Peter Adamson | M | - | - | |
| Ian Gilham | M | 64 | - | |
| Robert Ruffolo | M | 74 | 16 years | |
| Paul A. Allaire | M | - | - | |
| Thierry Loriot | M | - | - | |
| Donald F. McHenry | M | 87 | - | |
| David M. Pernock | M | 69 | 16 years | |
| Peter John Murray | M | - | - | |
| David Pompliano | M | - | 5 years | |
| Stephen A. Ross | M | 54 | 5 years | |
| Lucy Shapiro | M | 83 | 5 years | |
| Mark Berger | M | 69 | 5 years | |
| Rupert Bondy | M | 62 | - | |
| David Laskow-Pooley | M | 69 | 8 years | |
| Gary W. Christianson | M | 69 | 2 years | |
| Jennie Younger | F | - | 5 years | |
| Eddie J. Gray | M | 64 | 12 years | |
| David Imperiali | M | - |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | 4 years |
| John B. Elliot | M | 72 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 74 | 74.00% |
| Belgium | 14 | 14.00% |
| Sweden | 10 | 10.00% |
| Ireland | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christopher Tovey
- Personal Network